| 标题 |
Safety and efficacy of switching to bictegravir–lenacapavir versus continuing bictegravir–emtricitabine–tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet HIV 作者:Eric G Meissner; Moti Ramgopal; Peter J Ruane; William Sanchez; Gordon Crofoot; et al 出版日期:2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)